The needle device market is forecast to grow to over $6.8bn by 2033, according to analysis by GlobalData. Novo Nordisk’s investor relations manager David Heiberg Landsted confirmed the current ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...